Gliomatosis cerebri other imaging findings

Revision as of 18:38, 2 October 2015 by Sujit Routray (talk | contribs)
Jump to navigation Jump to search

Gliomatosis cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gliomatosis cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gliomatosis cerebri other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gliomatosis cerebri other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gliomatosis cerebri other imaging findings

CDC on Gliomatosis cerebri other imaging findings

Gliomatosis cerebri other imaging findings in the news

Blogs on Gliomatosis cerebri other imaging findings

Directions to Hospitals Treating Gliomatosis cerebri

Risk calculators and risk factors for Gliomatosis cerebri other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Other imaging studies for gliomatosis cerebri include MR spectroscopy (elevated choline/creatine ratio, choline/NAA ratio, and myoinositol), MR perfusion (low/normal relative cerebral blood flow), PET scan (markedly decreased accumulation of [18F]-fluorodeoxyglucose on F-18 FDG PET images, hypermetabolism on C-11 methionine PET images, and marked increase in cerebral blood flow on 15(O)-water PET images), and bone scan (metastasis to bones).[1]

Other Imaging Findings

Other imaging studies for gliomatosis cerebri include MR spectroscopy (elevated choline/creatine ratio, choline/NAA ratio, and myoinositol), MR perfusion (low/normal relative cerebral blood flow), PET scan (markedly decreased accumulation of [18F]-fluorodeoxyglucose on F-18 FDG PET images, hypermetabolism on C-11 methionine PET images, and marked increase in cerebral blood flow on 15(O)-water PET images), and bone scan (metastasis to bones).[1]


1. MR Spectroscopy

Other imaging studies for gliomatosis cerebri include MR spectroscopy. Common findings are described below:[1]

2. MR Perfusion

Other imaging studies for gliomatosis cerebri include MR perfusion. Common findings are described below:[1]

  • ​Low/normal relative cerebral blood flow (no vascular hyperplasia)

3. PET

Other imaging studies for gliomatosis cerebri include PET scan. Common features are described below:[1]

4. Bone Scan

Bone scan may be performed to detect metastases of gliomatosis cerebri to bones.

References

  1. 1.0 1.1 1.2 1.3 1.4 Radiographic features of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri


Template:WikiDoc Sources